BMG Inc.

 
 
 
 

BMG has devoted itself to the development of better bio-material, which contributes to health and welfare of people across the world.

 
BMG’s bio-absorbable polymer is produced in ISO 13485 certified facilities and is supplied to customers worldwide with the brand name of “BioDegmer”.
Also, BMG is now advancing the development of medical adhesive “LYDEX” with superb safety and functuinality.
If you have any questions, please feel free to contact us.
 
 
 
 

What’s new

 
2026.08.05
Joint Research Achievement with Pusan National University — Announcement of Publication on Fibrous Scaffolds for Tissue Engineering Using Our Poly(D-lactic acid). You can find more details here. [external link]
2026.07.31
Our Representative Director received the 2026 Japanese Society for Biomaterials Award (Technology & Clinical) in recognition of a series of research and development achievements regarding the creation and clinical implementation of dextran-based tissue adhesives.
2026.07.30
We hereby announces that a change in Representative Director was resoled at the Board of Directors meeting on July 30, 2026.
2026.07.30
We have revamped our corporate brand in conjunction with the transition to a new management structure.
2026.04.10
Launch of “AZ PRESERVER,” a Preservation Solution Enabling Cell Storage at 4 °C.
2026.02.27
Selected as One of the “Top 10 Cell and Gene Therapy Companies 2026” by Medhealth Review, a Life Sciences Specialty Publication with a Presence Across the U.S., Europe, and Asia. You can find more details here. [external link]
2025.06.03
We are pleased to announce that we signed a joint research agreement with Kangstem Biotech Co., Ltd. on May 20th, 2025 and have begun joint development of a new cryopreservation material that applicable to regenerative medicines with three-dimensional cell structures such as organoids.
2025.03.13
Approved for the manufacture and sale of an absorbable reinforcement material “Lydex Sealant”.
 
 
 

Company Profile

Introducing BMG's company profile and history.
 
 
 

BMG's three business fields

BMG supports the improvement of technology in the field of next-generation regenerative medicine and the healthy health of people in three business fields.
 

Biomaterial field

Development and manufacturing of Japan's first bioabsorbable polymer for sutures
 

Medical device field

Manufacture and development of medical devices utilizing specialized technology in medical polymer chemistry

Life science field

Manufacture and sale of polymeric cryoprotectants and reagents for preserving human mesenchymal stem cells.
 
 
BMG Inc.
〒601-8023
45 Minamimatsunoki-cho, Higashikujo, Minami-ku, Kyoto 601−8023, JAPAN
+81-75-681-0787
 
 
©2026 BMG Inc.